Kimberly Manhard, Director at Inhibrx Biosciences, Inc. (INBX), sold 1,000 shares at $115.14 ($115K) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Open-market sale of $115k INBX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.14 | 500 | $58K | 49.9% |
| 2 | $115.80 | 500 | $58K | 50.1% |
| Total | $115.47 avg | 1,000 | $115K | 100% |
| Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |
| HRTX | SELL | 2020-12-23 | $200K | — | Filing → |